Carfilzomib therapy for relapsed myeloma: results of a UK multicentre experience.

Djebbari F., Hubenov H., Neelakantan P., Wolf J., Offer M., Khera A., Louka E., Vallance G., Kothari J., Moore S., Ramasamy K.

DOI

10.1111/bjh.16324

Type

Journal article

Publication Date

2020-02-01T00:00:00+00:00

Volume

188

Pages

e57 - e60

Keywords

carfilzomib, dose intensity, myeloma, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Multiple Myeloma, Oligopeptides, Recurrence, Retrospective Studies, United Kingdom

Permalink More information Close